- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Cases selected for the AskAnzal weekly PMCPA insight newsletter
Complaint alleged LinkedIn promotion and breach of an undertaking by AstraZeneca. PMCPA concluded the matter was outwith the…
Daiichi Sankyo facilitated an AF digital diagnosis opinion article on an independent news site, but its involvement was…
Theramex’s LinkedIn ‘About Us’ described its solutions as “innovative, effective and safe”. The PMCPA ruled this was misleading…
A GP complained about an allegedly unsolicited promotional email for Actonel Combi. The Panel found the recipient had…
A Times diabetes supplement funded and editorially controlled by Novo Nordisk included trial claims about unapproved liraglutide. The…
A pharmacist alleged an oncology team dinner was purely social. PMCPA found the three-course meal with wine went…
Resolor promo used “At last! A new way out of chronic constipation in women”. Appeal Board found no…
Health-professional website page combined a licensed product with pipeline products and implied they were “effective, high quality”. PMCPA…
PMCPA case summary: Director v Merck Sharp & Dohme (AUTH/3086/9/18). Case text not provided in CASE_TEXT, so details…
Efient leavepiece used prominent 15‑month subgroup/landmark data and downplayed overall bleeding risk. PMCPA ruled it misleading, inconsistent with…
One real case. One key lesson. Every week — free.